Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > The Role of Inflammation in Lung Cancer
Publication

Publications

The Role of Inflammation in Lung Cancer

Title
The Role of Inflammation in Lung Cancer
Type
Article in International Scientific Journal
Year
2014
Authors
Gomes, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Teixeira, AL
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Coelho, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Araujo, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rui Medeiros
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Other information
Authenticus ID: P-00G-28Z
Abstract (EN): Lung cancer remains a serious public health problem and is the first cause of cancer death worldwide, and the overall 5-year survival rate for all stages is 14-17 % for Non-small-cell lung cancer and 6 % for small-cell lung cancer. Clinical and epidemiologic studies have suggested a strong association among chronic infection, inflammation, and cancer. Immune system plays a critical role in maintaining tissue homeostasis, cell turnover, tissue remodeling, and preventing infection and cell transformation. The inflammatory component in the development of the neoplasm includes a diverse leukocyte population; these components are considered inflammatory tumor key factors promoting tumor progression due to its ability to release a variety of cytokines, chemokines, and cytotoxic mediators such as reactive oxygen species (ROS), metalloproteinases, interleukins, and interferons. Cancer-related inflammation affects many aspects of malignancy, including the proliferation and survival of malignant cells, angiogenesis, tumor metastasis, and tumor response to chemotherapeutic drugs and hormones. Moreover, epidemiologic studies and meta-analysis have shown that prolonged use of non-steroid anti-inflammatory (NSAID) drugs reduces the risk of several solid tumor including lung cancer. Strong lines of evidence suggest that the chemopreventive properties of chronic NSAID administration are based on their COX-inhibitory activity. However, the prevention is a much better and more economical way to fight against cancer than treating an already advanced and often incurable disease.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 23
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Influence of TGFB1+869T > c polymorphism in non-small cell lung cancer (NSCLC) risk (2009)
Other Publications
Teixeira, AL; Araujo, A; Coelho, A; Gomes, M; Pereira, C; Ribeiro, R; Rui Medeiros
Influence of IL-4-590C/T polymorphism in Non-Small Cell Lung Cancer (NSCLC) susceptibility (2009)
Other Publications
Gomes, M; Coelho, A; Araujo, A; Catarino, R; Nogal, A; Teixeira, AL; Rui Medeiros
IL-6 polymorphism in non-small cell lung cancer: a prognostic value? (2015)
Article in International Scientific Journal
Gomes, M; Coelho, A; Araujo, A; Azevedo, A; Teixeira, AL; Catarino, R; Rui Medeiros
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-12 at 16:16:07 | Privacy Policy | Personal Data Protection Policy | Whistleblowing